Vaccine Development

Provides support for the development of new drugs and therapies, including design of experiments (DOE), protein formulation, and vaccine development.



Vaccine Development and Testing

Our company has a strong track record in the formulation development and testing of vaccines for a range of infectious diseases and other indications.

We offer a range of services to support the development and optimization of vaccines, including:

  • Vaccine formulation and production: We have experience with a variety of vaccine platforms, including subunit, protein, and liposomal vaccines, and can develop stable and immunogenic formulations using a range of excipients and technologies. We also have the capacity to produce small-scale batches of vaccines for preclinical toxicology and efficacy studies.
  • Immunogenicity testing: We use a variety of in vitro and in vivo assays to evaluate the immunogenic potential of vaccine candidates, including ELISA and animal models. We can measure antibody titers by ELISA.
  • Safety testing: We conduct comprehensive safety evaluations of vaccine candidates using a range of in vitro assays, including sub-visible particle analysis, vaccine integrity, and antigen-adjuvant interactions.
If you are looking to develop a new vaccine or need support with an existing vaccine project, we can provide the expertise and resources you need to succeed.